Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
38.2M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$377M
-
Value change
-
+$11.8M
-
Put/Call ratio
-
0
-
Number of buys
-
53
-
Number of sells
-
-46
-
Price
-
$9.85
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2018
131 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2018.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.2M shares
of 119M outstanding shares and own 32.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.7M shares), BVF INC/IL (5.19M shares), Vanguard Group Inc (3.44M shares), LANSDOWNE PARTNERS (UK) LLP (2.65M shares), GREAT POINT PARTNERS LLC (2.18M shares), STATE STREET CORP (2M shares), FMR LLC (1.96M shares), WASATCH ADVISORS INC (1.89M shares), WELLINGTON MANAGEMENT GROUP LLP (1.77M shares), and Invesco Ltd. (751K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.